Overprescribing of antibiotics to children in rural Vietnam

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 6-7, 2005, Pages 442-448

  Larsson, Mattias ^a   Falkenberg, Torkel ^a   Dardashti, Alain ^a   Ekman, Tomi ^a   Törnquist, Sam ^b,c   Kim Chuc, Nguyen Thi ^d   Hansson, Lars Olof ^a   Kronvall, Göran ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b BACH MAI HOSPITAL   (Viet Nam)

^c Vietnam Sweden Health Co operation   (Viet Nam)

^d HANOI MEDICAL UNIVERSITY   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ATROPINE; C REACTIVE PROTEIN; CHLORAMPHENICOL; CORTICOSTEROID; COTRIMOXAZOLE; EPHEDRINE; GENTAMICIN; PARACETAMOL; PENICILLIN G; SALBUTAMOL; THEOPHYLLINE; VITAMIN;

APLASTIC ANEMIA; ARTICLE; ASTHMA; BLOOD SAMPLING; BRONCHITIS; CAREGIVER; CHILD CARE; CONTROLLED STUDY; DIARRHEA; DRUG COST; DRUG UTILIZATION; ENTERITIS; FEMALE; FEVER; HEALTH CARE COST; HEALTH CARE SYSTEM; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PANCYTOPENIA; PNEUMONIA; PRESCHOOL CHILD; PRESCRIPTION; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RESPIRATORY TRACT INFECTION; RISK BENEFIT ANALYSIS; RURAL AREA; SORE THROAT; TONSILLITIS; URINARY TRACT INFECTION; VIET NAM;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; COMMUNITY HEALTH CENTERS; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; INFANT; MALE; RURAL POPULATION; VIETNAM;

EID: 22844433750     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540510036615     Document Type: Article

References (22)

1. Falkenherg T, Nguyen TB, Larsson M, Nguyen TD, Tomson G. Pharmaceutical sector in transition: a cross sectional study in Vietnam. Southeast Asian J Trop Med Public Health 2000;31:590-7.
2. Lönnroth K, Thuong LM, Linh PD, Diwan V. Risks and benefits of private health care: exploring physicians' views on private health care in Ho Chi Minh City, Vietnam. Health Policy 1998;45:81-97.
3. Trostle J. Inappropriate distribution of medicines by professionals in developing countries. Social Science & Medicine 1996;42:1117-20.
4. Larsson M, Kronvall G, Chuc NTK, Karlsson I, Lager F, Hanh HD, et al. Antibiotic medication and bacterial resistance to antibiotics: a survey of children in a Vietnamese community. Tropical Medicine and International Health 2000;5:711-21.
5. Barbosa TM, Levy SB. The impact of antibiotic use on resistance development and persistence. Drug Resist Updat 2000;3:303-11.
6. Isaacman DJ, Burke BL. Utility of the serum C-reactive protein for detection of occult bacterial infection in children. Archives of Pediatrics Adolescent Medicine 2002;156: 905-9.
7. Babu G, Ganguly NK, Singhi S, Walia BN. Value of C-reactive protein concentration in diagnosis and management of acute lower respiratory infections. Trop Geogr Med 1989; 41:309-15.
8. Hansson LO, Carlsson I, Hansson E, Hovelius B, Svensson P, Tryding N. Measurement of C-reactive protein and the erythrocyte sedimentation rate in general practice. Scand J Prim Health Care 1995;13:39-45.
9. Putto A, Ruuskanen O, Meurman O, Ekblad H, Korvenranta H, Mertsola J, et al. C-reactive protein in the evaluation of febrile illness. Arch Dis Child 1986;61:24-9.
10. Póvoa P, Coelho L, Almeida E, Fernandes A, Mealha R, Moreira P, Sabino H. C-reactive protein as a marker of infection in critically ill patients. Clinical Microbiology and Infection 2005;11:101-8.
11. Hopstaken RM, Stobberingh EE, Knottnerus JA, Muris JWM, Nelemans P, Rinkens PELM, Dinant GJ. Clinical items not helpful in differentiating viral from bacterial lower respiratory tract infections in general practice. Journal of Clinical Epidemiology 2005;58:175-83.
12. Hopstaken RM, Muris JW, Knottnerus JA, Kester AD, Rinkens PE, Dinant GJ. Contributions of symptoms, signs, erythrocyte sedimentation rate, and C-reactive protein to a diagnosis of pneumonia in acute lower respiratory tract infection. Br J Gen Pract 2003;53:358-64.
13. Dahler-Eriksen BS, Lauritzen T, Lassen JF, Lund ED, Brandslund I. Near-patient test for C-reactive protein in general practice: assessment of clinical, organizational, and economic outcomes. Clinical Chemistry 1999;45:478-85.
14. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
15. Chirouze C, Schuhmacher H, Rabaud C, Gil H, Khayat N, Estavoyer JM, et al. Low serum procalcitonin level accurately predicts the absence of bacteraemia in adult patients with acute fever. Clin Infect Dis 2002;35:156-61.
16. van Rossum AMC, Wulkan RW, Oudesluys-Murphy AM. Procalcitonin as an early marker of infection in neonates and children. Lancet Infectious Diseases 2004;4:620-30.
17. Peltola H, Jaakkola M. C-reactive protein in early detection of bacteraemic versus viral infections in immunocompetent and compromized children. J Pediatr 1988;113:641-6.
18. Kunin CM, Liu YC. Excessive use of antibiotics in the community associated with delayed admission and masked diagnosis of infectious diseases. J Microbiol Immunol Infect 2002;35:141-6.
19. Korppi M, Kröger L. C-reactive protein in viral and bacterial respiratory infection in children. Scand J. Infect Dis 1993; 25:207-13.
20. Tomson G, Diwan V, Angunawela I. Paediatric prescribing in outpatient care. An example from Sri Lanka. Eur J Clin Pharmacol 1990;39:469-73.
21. Hogerzeil HV, Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, et al. Field tests for rational drug use in 12 developing countries. Lancet 1993;342:1408-10.
22. Chuc NT, Tomson G. 'Doi moi' and private pharmacies: a case study on dispensing and financial issues in Hanoi, Vietnam. Eur J Clin Pharmacol 1999;55:325-32.